[1]熊巍,王贵梅.抗骨质疏松胶囊对绝经后骨质疏松症患者骨密度及骨代谢生化指标的影响[J].西部中医药,2022,35(03):104-107.[doi:10.12174/j.issn.2096-9600.2022.03.23]
　XIONG Wei,WANG Guimei.Influence of Anti-osteoporosis Capsules on Bone Mineral Density and Bone Metabolism Biochemical Markers in Patients with Postmenopausal Osteoporosis[J].Western Journal of Traditional Chinese Medicine,2022,35(03):104-107.[doi:10.12174/j.issn.2096-9600.2022.03.23]
点击复制

抗骨质疏松胶囊对绝经后骨质疏松症患者骨密度及骨代谢生化指标的影响
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
35
期数:
2022年03期
页码:
104-107
栏目:
出版日期:
2022-03-15

文章信息/Info

Title:
Influence of Anti-osteoporosis Capsules on Bone Mineral Density and Bone Metabolism Biochemical Markers in Patients with Postmenopausal Osteoporosis
作者:
熊巍, 王贵梅
四川省骨科医院，四川 成都 610041
Author(s):
XIONG Wei, WANG Guimei
Sichuan Provincial Orthopedic Hospital, Chengdu 610041, China
关键词:
骨质疏松症; 绝经后; 骨密度; 骨代谢生化指标
Keywords:
osteoporosis;  postmenopausal; BMD; bone metabolism biochemical markers
分类号:
R681
DOI:
10.12174/j.issn.2096-9600.2022.03.23
文献标志码:
B
摘要:
目的探讨抗骨质疏松胶囊对绝经后骨质疏松症患者骨密度及骨代谢生化指标的影响。 方法将骨质疏松症患者80例随机分成观察组和对照组各40例。对照组予碳酸钙D3片、骨化三醇软胶囊及阿仑膦酸钠片治疗，观察组在对照组基础上加抗骨质疏松胶囊。治疗6个月后比较两组患者腰椎骨密度（bone mineral density，BMD）、髋部BMD及血清钙（Ca）、磷（P）、甲状旁腺激素（parathyroid hormone，PTH）、25-（OH）VitD、Ⅰ型胶原羧基端肽β特殊序列（β-C-terminal telopeptide of type Ⅰ collagen，β-CTX）、Ⅰ型原胶原氨基端延长肽（propeptide of type 1 procollagen，PINP）、骨碱性磷酸酶（bone specific alkaline phosphatase，BALP）、骨钙素（bone gla protein，BGP）。 结果治疗后两组患者Ca、P、PTH比较差异无统计学意义（P＞0.05）。治疗后观察组患者腰椎BMD、髋部BMD、25-（OH）VitD、PINP、BALP、BGP较对照组高，β-CTX较对照度低，差异有统计学意义（P＜0.05）。 结论抗骨质疏松胶囊可以影响绝经后骨质疏松症患者骨代谢生化标志物，通过促进骨形成、抑制骨吸收提高骨密度。
Abstract:
ObjectiveTo discuss the effects of anti-osteoporosis capsules on bone mineral density (BMD) and bone metabolism biochemical markers in patients with postmenopausal osteoporosis. MethodsEighty patients were randomized into the observation group and the control group with 40 cases in each group. The control group was treated by calcium carbonate D3 tablets, calcitriol soft capsules and alendronate sodium tablets, and the observation group took anti-osteoporosis capsules based on the therapy the control group accepted. To compare lumbar BMD, sciatic BMD, the levels of serum calcium(Ca) and phosphorus(P), PTH, 25-(OH)VitD, β-CTX, PINP, BALP and BGP between both groups after six months of treatment. ResultsThe difference presented no statistical meaning in the levels of Ca, P and PTH between both groups after treating (P>0.05). After the treatment, lumbar BMD, sciatic BMD, 25-(OH)VitD, PINP, BALP and BGP of the observation group were higher than these of the control group, β-CTX was lower than that of the control group, and the difference had statistical meaning (P<0.05). ConclusionAnti-osteoporosis capsules could influence bone metabolism biochemical markers in patients with postmenopausal osteoporosis, and it could raise BMD by promoting bone formation and inhibiting bone resorption..

相似文献/References:

[1]谢栋,陈大军,马国亮,等.原发性骨质疏松症的骨密度与中医脏腑辨证的相关性研究*[J].西部中医药,2015,28(02):82.
[2]梁敏.绝经后骨质疏松症42例护理体会[J].西部中医药,2015,28(12):129.
[3]张彩凤,程卫东△,王彩霞,等.玫参胶囊治疗围绝经期骨质疏松症60例[J].西部中医药,2012,25(05):16.
　ZHANG Cai-feng,CHENG Wei-dong,WANG Cai-xia,et al.MeiShen Capsule in Treating 60 Cases of Menopausal Osteoporosis[J].Western Journal of Traditional Chinese Medicine,2012,25(03):16.
[4]张德宏,李晶.老年骨质疏松症的病因病机及防治原则探析[J].西部中医药,2013,26(03):90.
　ZHANG Dehong,LI Jing.The Etiology, Pathogenesis and Prevention Principles of Senile Osteoporosis[J].Western Journal of Traditional Chinese Medicine,2013,26(03):90.
[5]李晶,宋敏△,罗晓,等.淫羊藿总黄酮对去势大鼠股骨骨组织形态学及生物力学的影响*[J].西部中医药,2014,27(07):13.
　LI Jing,SONG Min,LUO Xiao,et al.Effects of Total Flavonoids of Epimedium on Biodynamics and Bone Morphological Metrology of Ovariectomized Rats[J].Western Journal of Traditional Chinese Medicine,2014,27(03):13.
[6]李非,李红专,叶丙霖.原发性骨质疏松症的中医药研究现状[J].西部中医药,2016,29(03):136.
　LI Fei,LI Hongzhuan,YE Binlin.Research Status of Primary Osteoporosis[J].Western Journal of Traditional Chinese Medicine,2016,29(03):136.
[7]薄云,夏冰杰,赵丽艳,等.疏肝滋肾汤治疗绝经后女性骨关节炎的临床观察[J].西部中医药,2016,29(07):93.
　BO Yun,XIA Bingjie,ZHAO Liyan,et al.Clinical Observation on ShuGan ZiShen Tang in Osteoarthritis of the Female Patients after the Menopause[J].Western Journal of Traditional Chinese Medicine,2016,29(03):93.
[8]王继宏,杨鹏玲.柴芍抗松汤治疗老年原发性骨质疏松症伴抑郁39例[J].西部中医药,2018,31(10):74.
　WANG Jihong,YANG Pengling.ChaiShao KangSong Decoction in Treating 39 Senile Patients Suffering Primary Osteoporosis Accompanying Depression[J].Western Journal of Traditional Chinese Medicine,2018,31(03):74.
[9]董林,雷宁波,邢涛,等.损伤胶囊对绝经后骨质疏松症患者疼痛、骨密度及骨代谢生化指标的影响[J].西部中医药,2017,30(11):8.
　DONG Lin,LEI Ningbo,XING Tao,et al.The Effects of Damage Capsules on the Pain, Bone Mineral Density and Biochemical Markers of Bone Metabolism of Postmenopausal Osteoporosis Patients[J].Western Journal of Traditional Chinese Medicine,2017,30(03):8.
[10]马风英.仙灵骨葆胶囊联合甲氨蝶呤治疗类风湿性关节炎继发骨质疏松症37例[J].西部中医药,2018,31(02):98.
　MA Fengying.XianLing GuBao Capsules Combined with Methotrexate in Treating 37 Rheumatiod Arthritis Patients with Secondary Osteoporosis[J].Western Journal of Traditional Chinese Medicine,2018,31(03):98.
[11]张长彪,彭冉东,赵军,等.益肾地黄汤联合利塞膦酸钠治疗肾阳虚型绝经后骨质疏松症45例[J].西部中医药,2017,30(04):1.
　ZHANG Changbiao,PENG Randong,ZHAO Jun,et al.YiShen Dihuang Tang Combined with Risedronate Sodium in the Treatment for 45 Cases of Postmenopausal Osteoporosis of Kidney Yang Deficiency Type[J].Western Journal of Traditional Chinese Medicine,2017,30(03):1.
[12]王想福,陈伟国,叶丙霖,等.从“肝肾同源”理论论治绝经后妇女骨质疏松症的研究进展[J].西部中医药,2019,32(06):155.
　WANG Xiangfu,CHEN Weiguo,YE Binglin,et al.Research Progress of Treatment for Osteoporosis of Postmenopausal Women Based on the Theory of ''Same Source of Liver and Kidney ''[J].Western Journal of Traditional Chinese Medicine,2019,32(03):155.
[13]赵军,邓强,彭冉东,等.综合干预方案调治绝经后骨质疏松症患者血瘀质的临床研究[J].西部中医药,2019,32(07):9.
　ZHAO Jun,DENG Qiang,PENG Randong,et al.Clinical Study on Treating Postmenopausal Osteoporosis of Blood Stagnation Constitution with Comprehensive Intervention Regimen[J].Western Journal of Traditional Chinese Medicine,2019,32(03):9.
[14]赵军,师建平.蒙药蓝刺头对去卵巢骨质疏松大鼠TGF-β1、UI、BMD的作用[J].西部中医药,2022,35(07):16.[doi:10.12174/j.issn.2096-9600.2022.07.04]
　ZHAO Jun,SHI Jianping.Influence of Mongolian Medicine Lancitou on TGF-β1, UI and BMD of Ovariectomized Rats with Osteoporosis[J].Western Journal of Traditional Chinese Medicine,2022,35(03):16.[doi:10.12174/j.issn.2096-9600.2022.07.04]
[15]郭晛,任艳玲.中医药基于骨髓脂肪组织能量代谢防治绝经后骨质疏松症机制探讨[J].西部中医药,2023,36(09):51.[doi:10.12174/j.issn.2096-9600.2023.09.11]
　GUO Xian,REN Yanling.Study on the Mechanism of TCM Intervention on Energy Metabolism of Bone Marrow Adipose Tissue in the Prevention and Treatment of Postmenopausal Osteoporosis[J].Western Journal of Traditional Chinese Medicine,2023,36(03):51.[doi:10.12174/j.issn.2096-9600.2023.09.11]

备注/Memo

备注/Memo:
熊巍（1980—），男，主治医师。研究方向：骨科疾病的中西医结合治疗。国家科技支撑计划项目（2012BAK21B01）。
更新日期/Last Update: 2022-06-24